51660-058 : Guaifenesin and Pseudoephedrine Hcl Oral Tablet, Extended Release


NDC: 51660-058
Labeler: Ohm Laboratories, Inc.
Product Type: Human OTC Drug
Drug Name:  Guaifenesin and Pseudoephedrine Hcl
Dosage Form: Oral Tablet, Extended Release
Application #: ANDA212542
Rev. Date: 


NDC Package Codes:

  • 51660-058-18: 1 BLISTER PACK IN 1 CARTON (51660‑058‑18) > 18 TABLET, EXTENDED RELEASE IN 1 BLISTER PACK

Active Ingredients:

  • Guaifenesin
  • Pseudoephedrine

Dosage Strength:

  • 600 mg
  • 60 mg

Pharmaceutical Classes:

  • Adrenergic alpha-Agonists [MoA]
  • alpha-Adrenergic Agonist [EPC]

Related Products:

Based on records with the same trade name.
  • 51660-057 Guaifenesin and Pseudoephedrine Hcl Oral Tablet, Extended Release by Ohm Laboratories, Inc.
  • 0363-0134 Guaifenesin and Pseudoephedrine Hcl Oral Tablet, Extended Release by Walgreen Co.
  • 0363-9946 Guaifenesin and Pseudoephedrine Hcl Oral Tablet, Extended Release by Walgreen Co.
  • 11822-0046 Guaifenesin and Pseudoephedrine Hcl Oral Tablet, Extended Release by Rite Aid Corporation
  • 30142-137 Guaifenesin and Pseudoephedrine Hcl Oral Tablet, Extended Release by Kroger Company
  • 55111-798 Guaifenesin and Pseudoephedrine Hcl Oral Tablet, Extended Release by Dr. Reddys Laboratories Limited
  • 55111-799 Guaifenesin and Pseudoephedrine Hcl Oral Tablet, Extended Release by Dr. Reddys Laboratories Limited
  • 58602-833 Guaifenesin and Pseudoephedrine Hcl Oral Tablet, Extended Release by Aurohealth LLC
  • 58602-834 Guaifenesin and Pseudoephedrine Hcl Oral Tablet, Extended Release by Aurohealth LLC
  • 62207-827 Guaifenesin and Pseudoephedrine Hcl Oral Tablet, Extended Release by Granules India Ltd
  • 62207-828 Guaifenesin and Pseudoephedrine Hcl Oral Tablet, Extended Release by Granules India Ltd
  • 70677-0110 Guaifenesin and Pseudoephedrine Hcl Oral Tablet, Extended Release by Strategic Sourcing Services, LLC
  • 70677-1011 Guaifenesin and Pseudoephedrine Hcl Oral Tablet, Extended Release by Strategic Sourcing Services, LLC
  • 79481-1002 Guaifenesin and Pseudoephedrine Hcl Oral Tablet, Extended Release by Meijer

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 51660-058 QR Code

< Prev: 51660-057Next: 51660-061 >

Related Discussions:

Pseudoephedrine 60mg Triprolidine 2.5mg
want to know the indian company which are the largest manufacturer of this composition ## i am requiring tablet with the... 6 replies
pseudoephedrine white tablet with 44 527 written on one side
oval long white tablet with 44 527 written on one side is it pseudoephedrine or what mg of psd is n it ## 44 527 is Acet... 3 replies
pseudoephedrine pill 24hrs
is oblong white and has RX724 printed on it. sulfate or hydrochloride? ## RX724 is not found in a data search base clini... 2 replies
pseudoephedrine sulfate
Do I need a perscription for claritin d 24 hour? ## @big t, Even though the packaging says "prescription strength... 1 reply
pseudoephedrine containing medicines sold in india
WAHTS THE ROLE OF PSEUDOEPHEDRINE AND TRIPROLIDINE , AND WHY PSEUDOEPHEDRINE IS BEING CHANGED TO PHENYLPROPALOMINE. HOW ... 1 reply
pseudoephedrine L054
white oblong caplet ## I found your pill to be Pseudoephedrine HCL SR (120 mg). Pseudoephedrine is the generic name for ... 1 reply
60 mg pseudoephedrine hci
Can i take that many mg? ## It depends on what you are using it for, and the safety would depend on other pre-existing m... 3 replies
90 Mg Pseudoephedrine Hcl
My wife gave my 11 y.o. son a Mucinex DM tablet withj 60 mg pseudoephedrine HCL. I was not aware of this and gave him 2 ... 1 reply
Tramadol and pseudoephedrine
Is there an interaction with Tramadol HCL 50 and Pseudoephedrine HCI 120mg? ...or worded another way... I took a Tramado... 1 reply
Biowaiver for pseudoephedrine
Pseudoephedrine is a BCS class 3 compound. What is needed to get a biowaiver for an EU country (FDA has a more stricter ... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.